Pasithea Therapeutics Corp. KTTA
0.53 USD +0.16 (+44.02%)
At closeNov 3, 2026, 4:00 PM EST
0.50 -0.03 -5.47%
After hours · Nov 3, 4:00 PM ET
0.3477 Day range 0.5344
0.281 52-week range 2.06
- YTD
- -58.91%
- 1 year
- -35.05%
Financial health
Altman Z-Score
3.11 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.4×
FY 2020 5y median -0.6× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 0.2×
FY 2020 5y median 0.4× FY 2025
P/FCF -0.6×
FY 2020 5y median -0.7× FY 2025
EV/EBITDA 2.3×
FY 2020 5y median 1.4× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -167.7%
FY 2020 5y median -148.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -37.0%
FY 2020 5y median -37.0% FY 2025
ROIC -37.7%
FY 2020 5y median -37.7% FY 2025
ROA -33.9%
FY 2020 5y median -33.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -46.4%
FY 2020 FY 2025
EPS (diluted) 77.1%
FY 2020 FY 2025
Free Cash Flow -9.3%
FY 2020 FY 2025
Financial Health
Current Ratio 11.4×
FY 2020 5y median 11.4× FY 2025
Quick Ratio 11.4×
FY 2020 5y median 11.4× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 2.7×
FY 2020 5y median 2.7× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31